Comparison of the efficacy and safety of two different lasers in the treatment of melasma
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT201201318146N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
All patients suffering from melasma that referred for treatment in during 2012 to the shohada-e tajrish treatment center form the study population.
Study inclusion criteria:
-Age between 18 to 85 years old
- Fitzpatrick skin type I-V
- symmetric distribution of melasma the in both sides of patient's face
study exclusion criteria:
-usage of pigment reducing topical treatments 2 weeks prior to the study
-usage of peeling agents 2 weeks prior to the study
-laser therapy for melasma 1 month prior to the study
-a history of poor wound healing, or abnormal scarring
-pregnancy or breast feeding
-history of keloid
-high exposure to sunlight or UV light 1 month prior to the study
-concurrent active herpes simplex lesion of the skin
-suspected hypersensitivity to lidocaine
-bleeding disorders
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melanin Index. Timepoint: After laser therapy. Method of measurement: Multi Probe adaptor.
- Secondary Outcome Measures
Name Time Method